Evidence map›Paper›PMID 42353559›Full record

ArticleCurrent issues in molecular biology2026

Temperature-Dependent Binding of Forxiga to Human Serum Albumin: Fluorescence, Competitive Displacement and Thermodynamic Analysis.

Krastena Nikolova, Ivan Antonov, Victoria Ilieva, Valentina Gavazova, Daniela Virovska, Denitsa Nencheva, Silviya Abarova

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Krastena NikolovaDepartment of Physics and Biophysics, Faculty of Pharmacy, Medical University-Varna, 84 Tsar Osvoboditel Blvd., 9004 Varna, Bulgaria.ORCID 0000-0002-2617-4776
Ivan AntonovMedical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria.
Victoria IlievaDepartment of Anesthesiology and Intensive Care, University Hospital "Alexandrovska", Georgi Sofiiski Str. No. 1, 1000 Sofia, Bulgaria.
Valentina GavazovaClinic of Endocrinology, Military Medical Academy, 3 Sveti Georgi Sofiyski Str., 1606 Sofia, Bulgaria.
Daniela VirovskaMedical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria.
Denitsa NenchevaMedical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria.
Silviya AbarovaMedical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria.ORCID 0009-0001-1614-4282

Funding

This study is financed by the European Union-Next Generation EU, through the National 402 Recovery and Resilience Plan of the Republic of Bulgaria No. BG-RRP-2.004-0009-C02.
6 · The paper itself

Abstract

In this study, we investigated the interaction of a dapagliflozin-containing medicinal product (the commercial drug Forxiga

Indexed as

dapagliflozindrug–protein interactionfluorescence quenchingForxigahuman serum albuminthermodynamic analysis

Identifiers

PMID42353559
PMCPMC13298406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.